CD274, PD-L1

Catalogue number: CD274-0.5

CloneZR3
IsotypeIgG
Product Type Primary Antibodies
Units0.5 ml
HostRabbit
Application Immunohistochemistry (frozen)
Immunohistochemistry (paraffin)

Background
Programmed cell death ligand 1 (PD-L1) also known as cluster of differentiation (CD274) or B7 homolog 1 (B7-H1) is a type 1 transmembrane protein involved in the regulation of cellular and humoral immune responses. The interaction of PD-L1 with its receptor PD-1 provides both stimulatory and inhibitory signals in regulating T cell activation and tolerance during pregnancy, tissue allograft, autoimmune disease and malignant transformation. The binding of PD-L1 to PD-1 induces apoptosis or exhaustion in activated T cells, and blockade of this interaction has been shown to enhance the antitumor activity of T cells. PD-L1 is frequently over expressed in placenta, and many human tumours such as melanoma, diffuse large B-cell lymphoma, and carcinomas of the lung, bladder, breast, kidney and colon. Human CD274, PD-L1.

Source

Immunogen: KLH-conjugated linear peptide from human PD-L1

Product
Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide.**

Purification Method: Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide.**

Specificity

Species Reactivity: Human

Applications
IHC(C, P)

Working Concentration: (liquid conc.) 1:50-1:100

Pre-Treatment: Unmasking with Unmasking fluid E (Art. No. DE006) pH 9.0 or Unmasking fluid T (DE005) pH 8.0

Positive Control: Placenta, lung carcinoma (NSCLC)

Caution
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio​ accepts no liability for any inaccuracies or omissions in this information.

References
1. Ishida, Agata, Shibahara et al. (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. The EMBO journal, Vol. 11, Issue 11, pp. 3887-95 (PubMed). 2. Wang W, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2016) IFN-? up-regulates PD-L1 expression in human placenta mesenchymal stem cells and enhances cell ability to induce the differentiation of IL-10+ T cells from cord blood- and peripheral blood-derived T cells. PMID 26927379 3. Benjamin J. Chen, Bjoern Chapuy, Jing Ouyang, et al. (2013) PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies Clinical Cancer Research. CCR-13-0855

Protein Reference(s)

Database Name: UniProt

Accession number: Q9NZQ7 (PD1L1_HUMAN)

Species Accession: Human


Safety Datasheet(s) for this product:
NM_Sodium Azide
/wp-content/uploads/SDS/Antibody SDS with Sodium Azide Noridic-MUbio.pdf